Literature DB >> 1326557

Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain.

U Rauch1, L Karthikeyan, P Maurel, R U Margolis, R K Margolis.   

Abstract

We have obtained the complete coding sequence of neurocan, a chondroitin sulfate proteoglycan of rat brain which is developmentally regulated with respect to its molecular size, concentration, carbohydrate composition, sulfation, and immunocytochemical localization. Two degenerate oligonucleotides, based on amino acid sequence data from the proteoglycan isolated from adult brain by immunoaffinity chromatography with the 1D1 monoclonal antibody, were used as sense and antisense primers in the polymerase chain reaction with a brain cDNA library as template to generate an unambiguous cDNA probe. A second probe for the N-terminal portion of the early postnatal form of the proteoglycan was obtained by reverse transcription/polymerase chain reaction. The composite sequence of overlapping cDNA clones is 5.2-kilobases (kb) long, including 1.3 kb of 3'-untranslated sequence and 76 base pairs of 5'-untranslated sequence. An open reading frame of 1257 amino acids encodes a protein with a molecular mass of 136 kDa containing 10 peptide sequences present in the adult and/or early postnatal brain proteoglycans. The deduced amino acid sequence revealed a 22-amino acid signal peptide followed by an immunoglobulin domain, tandem repeats characteristic of the hyaluronic acid-binding region of aggregating proteoglycans, and an RGDS sequence. The C-terminal portion (amino acids 951-1215) has approximately 60% identity to regions in the C termini of the fibroblast and cartilage proteoglycans, versican and aggrecan, including two epidermal growth factor-like domains, a lectin-like domain, and a complement regulatory protein-like sequence. The central 595-amino acid portion of neurocan has no homology with other reported protein sequences. The proteoglycan contains six potential N-glycosylation sites and 25 potential threonine O-glycosylation sites. In the adult form of the proteoglycan (which represents the C-terminal half of neurocan) a single 32-kDa chondroitin 4-sulfate chain is linked at serin-944, whereas three additional potential chondroitin sulfate attachment sites (only two of which are utilized) are present in the larger proteoglycan species. A probe corresponding to a region of neurocan having no homology with versican or aggrecan hybridized with a single band at approximately 7.5 kb on Northern blots of mRNA from both 4-day and adult rat brain (but not with muscle, kidney, liver, or lung mRNA), indicating that the 1D1 proteoglycan of adult brain, containing a 68-kDa core protein, is generated by a developmentally regulated in vivo proteolytic processing of the 136-kDa species which is predominant in early postnatal brain.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326557

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.

Authors:  R J McKeon; M J Jurynec; C R Buck
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Neurocan is upregulated in injured brain and in cytokine-treated astrocytes.

Authors:  R A Asher; D A Morgenstern; P S Fidler; K H Adcock; A Oohira; J E Braistead; J M Levine; R U Margolis; J H Rogers; J W Fawcett
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

3.  Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.

Authors:  M L Lemons; J D Sandy; D K Anderson; D R Howland
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 4.  Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Authors:  K E Rhodes; J W Fawcett
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

Review 5.  Central nervous system lesions that can and those that cannot be repaired with the help of olfactory bulb ensheathing cell transplants.

Authors:  Manuel Nieto-Sampedro
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

6.  Are genetic variations the most important risk factors for development of hepatocellular carcinoma?

Authors:  Masafumi Ono; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2015-10-31       Impact factor: 7.527

7.  Expression of hyaluronan and the hyaluronan-binding proteoglycans neurocan, aggrecan, and versican by neural stem cells and neural cells derived from embryonic stem cells.

Authors:  Mary Abaskharoun; Marie Bellemare; Elizabeth Lau; Richard U Margolis
Journal:  Brain Res       Date:  2010-02-20       Impact factor: 3.252

Review 8.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

9.  The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons.

Authors:  H Yamada; B Fredette; K Shitara; K Hagihara; R Miura; B Ranscht; W B Stallcup; Y Yamaguchi
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

10.  Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

Authors:  James M Massey; Jeremy Amps; Mariano S Viapiano; Russell T Matthews; Michelle R Wagoner; Christopher M Whitaker; Warren Alilain; Alicia L Yonkof; Abdelnaby Khalyfa; Nigel G F Cooper; Jerry Silver; Stephen M Onifer
Journal:  Exp Neurol       Date:  2007-04-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.